Recommended guidelines for the conduct and evaluation of prognostic studies in veterinary oncology

Veterinary Pathology

Volumn 48, Issue 1, 2011, Pages 7-18

  Webster, J D ^a   Dennis, M M ^b   Dervisis, N ^c   Heller, J ^d   Bacon, N J ^e   Bergman, P J ^f   Bienzle, D ^g   Cassali, G ^h   Castagnaro, M ⁱ   Cullen, J ^j   Esplin, D G ^k   Pena L ^l   Goldschmidt, M H ^m   Hahn, K A ⁿ   Henry, C J ^o   Hellmen E ^p   Kamstock, D ^q   Kirpensteijn, J ^r   Kitchell, B E ^c   Amorim, R L ^s   Lenz, S D ^t   Lipscomb, T P ^u   McEntee, M ^v   McGill, L D ^k   McKnight, C A ^w   McManus, P M ^x   Moore, A S ^b   Moore, P F ^y   Moroff, S D ^z   Nakayama, H ^aa   Northrup, N C ^ab   Sarli, G ^ac   Scase, T ^ad   Sorenmo, K ^ae   Schulman, F Y ^u   Shoieb, A M ^af   Smedley, R C ^c   Spangler, W L ^ag   Teske, E ^r   Thamm, D H ^q   Valli, V E ^ah   Vernau, W ^y   von Euler, H ^p   Withrow, S J ^q   Weisbrode, S E ^ai   Yager, J ^aj   Kiupel, M ^c   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d CHARLES STURT UNIVERSITY   (Australia)

^e University of Florida College of Veterinary Medicine   (United States)

^f BrightHeart Veterinary Centers   (United States)

^g UNIVERSITY OF GUELPH   (Canada)

^h FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

ⁱ UNIVERSITY OF PADOVA   (Italy)

^j NORTH CAROLINA STATE UNIVERSITY   (United States)

^k ARUP LABORATORIES   (United States)

^l UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^m UNIVERSITY OF PENNSYLVANIA   (United States)

ⁿ Hill's Pet Nutrition Inc   (United States)

^o UNIVERSITY OF MISSOURI   (United States)

^p SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^q Department of Environmental and Radiological Health Sciences   (United States)

^r UTRECHT UNIVERSITY   (Netherlands)

^s SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^t PURDUE UNIVERSITY   (United States)

^u ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^v Department of Obstetrics Gynecology   (United States)

^w MPI RESEARCH   (United States)

^x IDEXX LABORATORIES   (United States)

^y UNIVERSITY OF CALIFORNIA   (United States)

^z ANTECH DIAGNOSTICS   (United States)

^aa UNIVERSITY OF TOKYO   (Japan)

^ab UNIVERSITY OF GEORGIA   (United States)

^ac UNIVERSITY OF BOLOGNA   (Italy)

^ad Bridge Pathology   (United Kingdom)

^ae UNIVERSITY OF PENNSYLVANIA   (United States)

^af PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^ag NSG Pathology   (United States)

^ah VDX VETERINARY DIAGNOSTICS   (United States)

^ai OHIO STATE UNIVERSITY   (United States)

^aj Yager Best Histovet   (Canada)

more..

Author keywords

cancer; guidelines; prognostication; standardization; veterinary oncology

Indexed keywords

ANIMALIA;

EID: 79951894710     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1177/0300985810377187     Document Type: Article

References (60)

1. Bailey D., Erb H., Williams L., Ruslander D., Hauck M.: Carboplatin and doxorubicin combination chemotherapy for the treatment of appendicular osteosarcoma in the dog. J Vet Intern Med 17:199-205, 2003.
2. Begg C., Cho M., Eastwood S., Horton R., Moher D., Olkin I., Pitkin R., Rennie D., Schulz KF, Simel D., Stroup DF: Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA 276:637-639, 1996.
3. Bradburn MJ, Clark TG, Love SB, Altman DG: Survival analysis: part II. Multivariate data analysis: an introduction to concepts and methods. Br J Cancer 89:431-436, 2003.
4. Bradburn MJ, Clark TG, Love SB, Altman DG: Survival analysis: part III. Multivariate data analysis: choosing a model and assessing its adequacy and fit. Br J Cancer 89:605-611, 2003.
5. Brazma A., Hingamp P., Quackenbush J., Sherlock G., Spellman P., Stoeckert C., Aach J., Ansorge W., Ball CA, Causton HC, Gaasterland T., Glenisson P., Holstege FC, Kim IF, Markowitz V., Matese JC, Parkinson H., Robinson A., Sarkans U., Schulze-Kremer S., Stewart J., Taylor R., Vilo J., Vingron M.: Minimum information about a microarray experiment (MIAME): toward standards for microarray data. Nat Genet 29:365-371, 2001.
6. Bustin SA, Benes V., Garson JA, Hellemans J., Huggett J., Kubista M., Mueller R., Nolan T., Pfaffl MW, Shipley GL, Vandesompele J., Wittwer CT: The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55:611-622, 2009.
7. Choi H., Charnsangavej C., Faria SC, Macapinlac HA, Burgess MA, Patel SR, Chen LL, Podoloff DA, Benjamin RS: Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol 25:1753-1759, 2007.
8. Christley RM, Reid SW: No significant difference: use of statistical methods for testing equivalence in clinical veterinary literature. J Am Vet Med Assoc 222:433-437, 2003.
9. Clark TG, Bradburn MJ, Love SB, Altman DG: Survival analysis: part I. Basic concepts and first analyses. Br J Cancer 89:232-238, 2003.
10. Clark TG, Bradburn MJ, Love SB, Altman DG: Survival analysis: part IV. Further concepts and methods in survival analysis. Br J Cancer 89:781-786, 2003.
11. Cregger M., Berger AJ, Rimm DL: Immunohistochemistry and quantitative analysis of protein expression. Arch Pathol Lab Med 130:1026-1030, 2006.
12. Deutsch EW, Ball CA, Berman JJ, Bova GS, Brazma A., Bumgarner RE, Campbell D., Causton HC, Christiansen JH, Daian F., Dauga D., Davidson DR, Gimenez G., Goo YA, Grimmond S., Henrich T., Herrmann BG, Johnson MH, Korb M., Mills JC, Oudes AJ, Parkinson HE, Pascal LE, Pollet N., Quackenbush J., Ramialison M., Ringwald M., Salgado D., Sansone SA, Sherlock G., Stoeckert CJ Jr, Swedlow J., Taylor RC, Walashek L., Warford A., Wilkinson DG, Zhou Y., Zon LI, Liu AY, True LD: Minimum information specification for in situ hybridization and immunohistochemistry experiments (MISFISHIE). Nat Biotechnol 26:305-312, 2008.
13. Dohoo I., Martin W., Stryhn H.: Cohort studies. In: Veterinary Epidemiologic Research, ed. Dohoo I, Martin W, Stryhn H, pp. 151-- 162. AVC, Charlottetown, Prince Edward Island, Canada, 2003.
14. Eisenhauer EA, Therasse P., Bogaerts J., Schwartz LH, Sargent D., Ford R., Dancey J., Arbuck S., Gwyther S., Mooney M., Rubinstein L., Shankar L., Dodd L., Kaplan R., Lacombe D., Verweij J.: New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228-247, 2009.
15. Field D., Garrity G., Gray T., Morrison N., Selengut J., Sterk P., Tatusova T., Thomson N., Allen MJ, Angiuoli SV, Ashburner M., Axelrod N., Baldauf S., Ballard S., Boore J., Cochrane G., Cole J., Dawyndt P., De Vos P., DePamphilis C., Edwards R., Faruque N., Feldman R., Gilbert J., Gilna P., Glockner FO, Goldstein P., Guralnick R., Haft D., Hancock D., Hermjakob H., Hertz-Fowler C., Hugenholtz P., Joint I., Kagan L., Kane M., Kennedy J., Kowalchuk G., Kottmann R., Kolker E., Kravitz S., Kyrpides N., Leebens-Mack J., Lewis SE, Li K., Lister AL, Lord P., Maltsev N., Markowitz V., Martiny J., Methe B., Mizrachi I., Moxon R., Nelson K., Parkhill J., Proctor L., White O., Sansone SA, Spiers A., Stevens R., Swift P., Taylor C., Tateno Y., Tett A., Turner S., Ussery D., Vaughan B., Ward N., Whetzel T., San Gil I., Wilson G., Wipat A.: The minimum information about a genome sequence (MIGS) specification. Nat Biotechnol 26:541-547, 2008.
16. Fieten H., Spee B., Ijzer J., Kik MJ, Penning LC, Kirpensteijn J.: Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma. Vet Pathol 46:869-877, 2009.
17. Garzotto CK, Berg J., Hoffmann WE, Rand WM: Prognostic significance of serum alkaline phosphatase activity in canine appendicular osteosarcoma. J Vet Intern Med 14:587-592, 2000.
18. Gieger TL, Theon AP, Werner JA, McEntee MC, Rassnick KM, DeCock HE: Biologic behavior and prognostic factors for mast cell tumors of the canine muzzle: 24 cases (1990-2001). J Vet Intern Med 17:687-692, 2003.
19. Guenin S., Mauriat M., Pelloux J., Van Wuytswinkel O., Bellini C., Gutierrez L.: Normalization of qRT-PCR data: the necessity of adopting a systematic, experimental conditions-specific, validation of references. J Exp Bot 60:487-493, 2009.
20. Guyatt G.: Determining prognosis and creating clinical decision rules. In: Clinical Epidemiology: How to Do Clinical Practice Research, ed. Haynes RB, Sackett DL, Guyatt GH, Tugwell P, 3rd ed., pp. 323-355. Lippincott Williams & Wilkins, Philadelphia, PA, 2006.
21. Hall PA, Lane DP: p53 in tumour pathology: can we trust immunohistochemistry? Revisited! J Pathol 172:1-4, 1994.
22. Hall PA, McCluggage WG: Assessing p53 in clinical contexts: unlearned lessons and new perspectives. J Pathol 208:1-6, 2006.
23. Harrell FE Jr, Lee KL, Matchar DB, Reichert TA: Regression models for prognostic prediction: advantages, problems, and suggested solutions. Cancer Treat Rep 69:1071-1077, 1985.
24. Hillers KR, Dernell WS, Lafferty MH, Withrow SJ, Lana SE: Incidence and prognostic importance of lymph node metastases in dogs with appendicular osteosarcoma: 228 cases (1986-2003). J Am Vet Med Assoc 226:1364-1367, 2005.
25. Ishiguro T., Kadosawa T., Takagi S., Kim G., Ohsaki T., Bosnakovski D., Okumura M., Fujinaga T.: Relationship of disease progression and plasma histamine concentrations in 11 dogs with mast cell tumors. J Vet Intern Med 17:194-198, 2003.
26. Justice AC, Covinsky KE, Berlin JA: Assessing the generalizability of prognostic information. Ann Intern Med 130:515-524, 1999.
27. Luong RH, Baer KE, Craft DM, Ettinger SN, Scase TJ, Bergman PJ: Prognostic significance of intratumoral microvessel density in canine soft-tissue sarcomas. Vet Pathol 43:622-631, 2006.
28. Maier T., Guell M, Serrano L: Correlation of mRNA and protein in complex biological samples. FEBS Lett 583:3966-3973, 2009.
29. McShane LM, Altman DG, Sauerbrei W., Taube SE, Gion M., Clark GM: REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer 93:387-391, 2005.
30. Misdorp W.: Tumors of the mammary gland. In: Tumors in Domestic Animals, ed. Meuten DJ, 4th ed., pp. 575-606. Iowa State Press, Ames, IA, 2002.
31. Moher D., Schulz KF, Altman DG: The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357:1191-1194, 2001.
32. Molander-McCrary H., Henry CJ, Potter K., Tyler JW, Buss MS: Cutaneous mast cell tumors in cats: 32 cases (1991-1994). J Am Anim Hosp Assoc 34:281-284, 1998.
33. Mullins MN, Lana SE, Dernell WS, Ogilvie GK, Withrow SJ, Ehrhart EJ: Cyclooxygenase-2 expression in canine appendicular osteosarcomas. J Vet Intern Med 18:859-865, 2004.
34. Northrup NC, Harmon BG, Gieger TL, Brown CA, Carmichael KP, Garcia A., Latimer KS, Munday JS, Rakich PM, Richey LJ, Stedman NL, Cheng AL, Howerth EW: Variation among pathologists in histologic grading of canine cutaneous mast cell tumors. J Vet Diagn Invest 17:245-248, 2005.
35. Northrup NC, Howerth EW, Harmon BG, Brown CA, Carmicheal KP, Garcia AP, Latimer KS, Munday JS, Rakich PM, Richey LJ, Stedman NL, Gieger TL: Variation among pathologists in the histologic grading of canine cutaneous mast cell tumors with uniform use of a single grading reference. J Vet Diagn Invest 17:561-564, 2005.
36. Ozaki K., Yamagami T., Nomura K., Narama I.: Mast cell tumors of the gastrointestinal tract in 39 dogs. Vet Pathol 39:557-564, 2002.
37. Patnaik AK, Ehler WJ, MacEwen EG: Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Vet Pathol 21:469-474, 1984.
38. Peters TJ: Multifarious terminology: multivariable or multivariate? univariable or univariate? Paediatr Perinat Epidemiol 22:506, 2008.
39. Polton GA, Brearley MJ, Powell SM, Burton CA: Impact of primary tumour stage on survival in dogs with solitary lung tumours. J Small Anim Pract 49:66-71, 2008.
40. Ramos-Vara JA, Kiupel M., Baszler T., Bliven L., Brodersen B., Chelack B., Czub S., Del Piero F., Dial S., Ehrhart EJ, Graham T., Manning L., Paulsen D., Valli VE, West K.: Suggested guidelines for immunohistochemical techniques in veterinary diagnostic laboratories. J Vet Diagn Invest 20:393-413, 2008.
41. Riley RD, Abrams KR, Lambert PC, Sutton AJ, Altman DG: Where next for evidence synthesis of prognostic markter studies? Improving the quality and reporting of primary studies to facilitate clinically relevant evidence-based results. In: Advances in Statistical Methods for the Health Sciences: Application to Cancer AIDS Studies, Genome Sequence Analysis, and Survival Analysis, ed. Auget JL, Balakrishanan N, Mesbah M, Molenberghs G, pp. 39-58. Birkhauser, Boston, MA, 2007.
42. Romansik EM, Reilly CM, Kass PH, Moore PF, London CA: Mitotic index is predictive for survival for canine cutaneous mast cell tumors. Vet Pathol 44:335-341, 2007.
43. Save V., Nylander K., Hall PA: Why is p53 protein stabilized in neoplasia? Some answers but many more questions? J Pathol 184:348-350, 1998.
44. Schwartz LH, Bogaerts J., Ford R., Shankar L., Therasse P., Gwyther S., Eisenhauer EA: Evaluation of lymph nodes with RECIST 1.1. Eur J Cancer 45:261-267, 2009.
45. Simon R., Altman DG: Statistical aspects of prognostic factor studies in oncology. Br J Cancer 69:979-985, 1994.
46. Spangler WL, Kass PH: The histologic and epidemiologic bases for prognostic considerations in canine melanocytic neoplasia. Vet Pathol 43:136-149, 2006.
47. Sullivan CA, Chung GG: Biomarker validation: in situ analysis of protein expression using semiquantitative immunohistochemistry-based techniques. Clin Colorectal Cancer 7:172-177, 2008.
48. Takei H., Kurosumi M., Yoshida T., Ninomiya J., Hagiwara Y., Kamimura M., Hayashi Y., Tozuka K., Suemasu K., Inoue K., Tabei T.: Current trends of sentinel lymph node biopsy for breast cancer: a surgeon's perspective. Breast Cancer 14:362-370, 2007.
49. Taylor CF, Field D., Sansone SA, Aerts J., Apweiler R., Ashburner M., Ball CA, Binz PA, Bogue M., Booth T., Brazma A., Brinkman RR, Michael Clark A., Deutsch EW, Fiehn O., Fostel J., Ghazal P., Gibson F., Gray T., Grimes G., Hancock JM, Hardy NW, Hermjakob H., Julian RK Jr, Kane M., Kettner C., Kinsinger C., Kolker E., Kuiper M., Le Novere N., Leebens-Mack J., Lewis SE, Lord P., Mallon AM, Marthandan N., Masuya H., McNally R., Mehrle A., Morrison N., Orchard S., Quackenbush J., Reecy JM, Robertson DG, Rocca-Serra P., Rodriguez H., Rosenfelder H., Santoyo-Lopez J., Scheuermann RH, Schober D., Smith B., Snape J., Stoeckert CJ Jr, Tipton K., Sterk P., Untergasser A., Vandesompele J., Wiemann S.: Promoting coherent minimum reporting guidelines for biological and biomedical investigations: the MIBBI project. Nat Biotechnol 26:889-896, 2008.
50. Taylor CF, Paton NW, Lilley KS, Binz PA, Julian RK Jr, Jones AR, Zhu W., Apweiler R., Aebersold R., Deutsch EW, Dunn MJ, Heck AJ, Leitner A., Macht M., Mann M., Martens L., Neubert TA, Patterson SD, Ping P., Seymour SL, Souda P., Tsugita A., Vandekerckhove J., Vondriska TM, Whitelegge JP, Wilkins MR, Xenarios I., Yates JR III, Hermjakob H.: The minimum information about a proteomics experiment (MIAPE). Nat Biotechnol 25:887-893, 2007.
51. Tian Q., Stepaniants SB, Mao M., Weng L., Feetham MC, Doyle MJ, Yi EC, Dai H., Thorsson V., Eng J., Goodlett D., Berger JP, Gunter B., Linseley PS, Stoughton RB, Aebersold R., Collins SJ, Hanlon WA, Hood LE: Integrated genomic and proteomic analyses of gene expression in mammalian cells. Mol Cell Proteomics 3:960-969, 2004.
52. von Elm E., Altman DG, Egger M., Pocock SJ, Gotzsche PC, Vandenbroucke JP: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61:344-349, 2008.
53. Von Euler H., Khoshnoud R., He Q., Khoshnoud A., Fornander T., Rutqvist LE, Skog S.: Time-dependent RNA degradation affecting cDNA array quality in spontaneous canine tumours sampled using standard surgical procedures. Int J Mol Med 16:979-985, 2005.
54. Wahl RL, Jacene H., Kasamon Y., Lodge MA: From RECIST to PERCIST: evolving Considerations for PET response criteria in solid tumors. J Nucl Med 50:122S-150S, 2009.
55. Warrington JA, Nair A., Mahadevappa M., Tsyganskaya M.: Comparison of human adult and fetal expression and identification of 535 housekeeping/maintenance genes. Physiol Genomics 2:143-147, 2000.
56. Webster JD, Kiupel M., Kaneene JB, Miller R., Yuzbasiyan-Gurkan V.: The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors. Vet Pathol 41:371-377, 2004.
57. Webster JD, Yuzbasiyan-Gurkan V., Kaneene JB, Miller R., Resau JH, Kiupel M.: The role of c-KIT in tumorigenesis: evaluation in canine cutaneous mast cell tumors. Neoplasia 8:104-111, 2006.
58. Williams LE, Packer RA: Association between lymph node size and metastasis in dogs with oral malignant melanoma: 100 cases (1987-2001). J Am Vet Med Assoc 222:1234-1236, 2003.
59. Wynford-Thomas D: P53 in tumour pathology: can we trust immunocytochemistry? J Pathol 166:329-330, 1992.
60. Yamagami T., Kobayashi T., Takahashi K., Sugiyama M.: Prognosis for canine malignant mammary tumors based on TNM and histologic classification. J Vet Med Sci 58:1079-1083, 1996.